Time to celebrate!
Our dear colleague and friend Bert Kwanten successfully defended his PhD. In his thesis, he used CRISPR−Cas9 screening to identify genes that influence the response to the cancer drug selinexor, which targets XPO1. The results of these screens laid the foundation for uncovering a novel allosteric mechanism by which selinexor mediates targeted degradation of XPO1.
It was a pleasure to share this special moment together with all members of our lab.
Our latest research is published in 𝘔𝘰𝘭𝘦𝘤𝘶𝘭𝘢𝘳 𝘛𝘩𝘦𝘳𝘢𝘱𝘺 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺:“𝐂𝐨𝐦𝐩𝐚𝐫𝐚𝐭𝐢𝐯𝐞 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐨𝐧𝐜𝐨𝐥𝐲𝐭𝐢𝐜 𝐯𝐢𝐫𝐮𝐬𝐞𝐬 𝐫𝐞𝐯𝐞𝐚𝐥𝐬 𝐨𝐩𝐩𝐨𝐬𝐢𝐧𝐠 𝐩𝐫𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞𝐬 𝐟𝐨𝐫 𝐠𝐥𝐢𝐨𝐛𝐥𝐚𝐬𝐭𝐨𝐦𝐚 𝐬𝐮𝐛𝐭𝐲𝐩𝐞𝐬” Glioblastoma
On Friday, June 26, Janne Van Hauwenhuyse successfully defended her PhD dissertation, Identification and Development of Novel Treatment Options for
Time to celebrate! Our dear colleague and friend Bert Kwanten successfully defended his PhD. In his thesis, he used CRISPR−Cas9
What happens when the DD lab steps out of the work environment? A day full of laughter, challenges, and great
